Bayer Gets Korean Imaging Technology | Chemical & Engineering News
Volume 86 Issue 8 | p. 18 | Concentrates
Issue Date: February 25, 2008

Bayer Gets Korean Imaging Technology

Department: Business

Bayer Schering Pharma has licensed worldwide rights to a novel fluorine-18 radiolabeling technology from FutureChem, part of South Korea's Asan Medical Center. Bayer says the technology can be used to label target-specific tracers for positron emission tomography and other molecular imaging techniques. FutureChem's labeling process includes a nucleophilic substitution reaction that, according to Bayer, results in yields 5 to 50 times larger than those achieved with existing technologies.

 
Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society

Leave A Comment

*Required to comment